STOCK TITAN

Ginkgo Bioworks president sells 41,172 shares

RSU footnotes describe a 75% vesting event on October 16 and separate awards vesting in equal quarterly installments over 12 quarters.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Ginkgo Bioworks Holdings, Inc.'s President & Founder, Reshma P. Shetty, reported conversion of 76,462 restricted stock units into Class A shares on October 16, 2026, in direct and spouse-held accounts. On October 19, she reported sales of 41,172 shares at $10.1430 per share to cover tax withholding; the footnotes state these were not discretionary trades, and no Rule 10b5-1 plan is reported.

Insider Shetty Reshma P.
Role See remarks
Sold 41,172 shs ($418K)
Approx. gross sale proceeds $418K
Type Security Shares Price Value
Sale Class A Common Stock F2 22,369 $10.143 $227K
Sale Class A Common Stock F2 18,803 $10.143 $191K
Exercise Restricted Stock Units F1, F3 29,279 -- --
Exercise Restricted Stock Units F1, F4 10,619 -- --
Exercise Restricted Stock Units F1, F3 26,802 -- --
Exercise Restricted Stock Units F1, F4 9,762 -- --
Exercise Class A Common Stock F1 29,279 -- --
Exercise Class A Common Stock F1 10,619 -- --
Exercise Class A Common Stock F1 26,802 -- --
Exercise Class A Common Stock F1 9,762 -- --
Holdings After Transaction: Restricted Stock Units — 126,563 contracts (Direct); Restricted Stock Units — 116,307 contracts (Indirect, By Spouse); Class A Common Stock — 453,951 shares (Direct); Class A Common Stock — 356,329 shares (Indirect, By Spouse)
Footnotes (4)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  2. F2. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
  3. F3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.
  4. F4. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.
Shares sold 41,172 shares October 19, 2026
Sale price $10.1430 per share October 19, 2026
Shares acquired through RSU conversion 76,462 shares October 16, 2026
Vesting portion 75% Vested October 16, 2026
Remaining vesting portion 25% Scheduled to vest January 21, 2027
Quarterly vesting schedule 12 quarters Equal quarterly installments
restricted stock unit financial
"Each restricted stock unit ("RSU") represents a contingent right"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
sell to cover financial
"funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
tax withholding obligations financial
"to cover tax withholding obligations"
equity incentive plans financial
"The Issuer's equity incentive plans allow the Issuer"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DNA shares did Reshma P. Shetty sell, and at what price?

Reshma P. Shetty reported sales of 41,172 shares at $10.1430 per share on October 19, 2026. The sales covered tax withholding obligations and were not discretionary trades; no Rule 10b5-1 plan is reported.

What RSU vesting schedules did DNA's Reshma P. Shetty report?

On October 16, 2026, 29,279 direct and 26,802 spouse-held RSUs were associated with a 75% vesting event; the remaining 25% will vest on January 21, 2027. Separate RSU amounts of 10,619 direct and 9,762 spouse-held shares vest in equal quarterly installments over the next 12 quarters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shetty Reshma P.

(Last)(First)(Middle)
C/O GINKGO BIOWORKS HOLDINGS
27 DRYDOCK AVENUE

(Street)
BOSTON MASSACHUSETTS 02210

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ginkgo Bioworks Holdings, Inc. [ DNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
See remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock10/16/2026M(1)29,279A(1)465,701D
Class A Common Stock10/16/2026M(1)10,619A(1)476,320D
Class A Common Stock10/19/2026S(2)22,369D$10.143453,951D
Class A Common Stock10/16/2026M(1)26,802A(1)365,370IBy Spouse
Class A Common Stock10/16/2026M(1)9,762A(1)375,132IBy Spouse
Class A Common Stock10/19/2026S(2)18,803D$10.143356,329IBy Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)10/16/2026M(1)29,279 (3) (3)Class A Common Stock29,279(1)9,759D
Restricted Stock Units(1)10/16/2026M(1)10,619 (4) (4)Class A Common Stock10,619(1)116,804D
Restricted Stock Units(1)10/16/2026M(1)26,802 (3) (3)Class A Common Stock26,802(1)8,934IBy Spouse
Restricted Stock Units(1)10/16/2026M(1)9,762 (4) (4)Class A Common Stock9,762(1)107,373IBy Spouse
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.
4. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.
Remarks:
President & Founder
/s/ Karen Tepichin, Attorney-in-Fact10/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading